A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa
Clinical trial NCT03083704 · COMPLETED
Trial details
- NCT number
- NCT03083704
- Sponsor
- Portola Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-26
- Primary completion
- 2017-09-28
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.